1 Clinical and Laboratory standards Institute.Performance standards for antimicrobial susceptibility testing;Twenty-Forth informational supplements.CLSI document M100-S24,Wayne,PA;CLSI,2014. 2 Stockmann C,Spigarelli MG,Campbell SC,et al.Considerations in the pharmacologic treatment and prevention of neonatal sepsis.Pediatric Drugs,2014,16:67-81. 3 Shah BA,Padbury JF.Neonatal sepsis: an old problem with new insights.Virulence,2014,5:170-178. 4 李耿,伍佰祥.新生儿细菌感染标记物的研究进展.中华儿科杂志,2007,45:674-678. 5 Azza Z,Labi B,Ahmed B,et al.Early diagnosis of neonatal sepsis: A molecular approach and detection of diagnostic markers versus conventional blood culture international.J Microbiol Res,2013,4:77-85. 6 王政力,余加林.新生儿败血症诊断新进展.中国当代儿科杂志,2013,15:236-240. 7 周建明,朱红梅,李建平,等.浙江地区新生儿血培养病原菌分布及耐药性分析.浙江预防医学,2008,20:9-11. 8 张申,沈波,王春新.新生儿凝固酶阴性葡萄球菌败血症病原菌分布及耐药性分析.临床儿科杂志,2009,27:1061-1063. 9 曾淑娟,丘惠娴.新生儿无乳链球菌败血症临床分析.中国妇幼保健,2013,28:3290-3291. 10 Paul M.Beta lactam antibiotic monotherapy versus betalactam-aminoglycoside antibiotic combination therapy for sepsis.Cochrane Database Syst Rev,2014,1:CD003344. 11 余丹阳.严峻耐药形势下碳青霉烯类抗生素的临床应用.中国感染与化疗杂志,2013,4:317-320.
